The Medicines for Human Use (Clinical Trials) Regulations 2004

PART 9 U.K. MISCELLANEOUS PROVISIONS

Construction of references to specified publications U.K.

53.—(1) Where any authorisation granted under these Regulations refers to a specified publication, but not to any particular edition of that publication, then, for the purpose of determining whether anything done, at a time when the authorisation is in force, is done in accordance with the authorisation, the reference shall, unless the authorisation otherwise expressly provides, be construed as a reference to the current edition of that publication as in force at that time.

(2) In this regulation any reference to the current edition of a specified publication as in force at a particular time is a reference to the edition of that publication in force, under whatever title, at that time together with any amendments, additions and deletions made to it up to that time.

(3) In this regulation, “specified publication” has the meaning given by [F1 regulation 321(1) of the 2012 Regulations].

Textual Amendments

F1 Words in reg. 53(3) substituted (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 60 (with Sch. 32)

Consequential and other amendments to enactments U.K.

54.   [F2 The provisions of the enactments specified in Schedule 10 are amended as there specified.]

Textual Amendments

F2 Reg. 54 revoked in part (1.10.2010) by The Health and Social Care Act 2008 (Commencement No.16, Transitory and Transitional Provisions) Order 2010 (S.I. 2010/807), art. 1(1)(b), Sch. 2

Revocations U.K.

55.  The enactments specified in column (1) of Schedule 11 are revoked to the extent specified in column (3) of that Schedule.

Transitional provisions U.K.

56.  The transitional provisions set out in Schedule 12 shall have effect.